checkAd

     583  0 Kommentare GlobeImmune Announces Second Quarter 2014 Financial Results - Seite 3

    Tarmogen is a registered trademark of GlobeImmune, Inc.

    Lesen Sie auch

    GLOBEIMMUNE CONTACT:
    Timothy C. Rodell M.D.
    President and Chief Executive Officer
    T: 303-625-2820
    information@globeimmune.com

    GLOBEIMMUNE MEDIA CONTACTS:
    Lena Evans or Tony Russo, Ph.D.
    Russo Partners, LLC
    T: 212-845-4262 or 212-845-4251
    lena.evans@russopartnersllc.com
    tony.russo@russopartnersllc.com

    GLOBEIMMUNE INVESTOR CONTACT:
    Susan Noonan
    S.A. Noonan Communications
    T: 917-513-5303
    susan@sanoonan.com


    Seite 3 von 3

    Verfasst von Marketwired
    2 im Artikel enthaltene WerteIm Artikel enthaltene Werte
    GlobeImmune Announces Second Quarter 2014 Financial Results - Seite 3 LOUISVILLE, CO--(Marketwired - August 15, 2014) - GlobeImmune, Inc. (NASDAQ: GBIM) today announced its second quarter 2014 corporate highlights and financial results. The net loss for the second quarter was $5.7 million, bringing the net loss for …